PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayNext phase of growth hinges on biologics, peptides, and drug-device combinations, say industry executives
)
premium
Indian CDMOs are expanding into biologics, GLP-1 peptides and sterile injectables to capture a larger share of the global drug manufacturing market.
Anjali Singh Mumbai
4 min read
Last Updated :
Oct 22 2026 | 11:16 PM
IST
For years, India’s contract development and manufacturing organisations (CDMOs) built their businesses on cost competitiveness and volumes in small-molecule drugs.


2 days ago
2

















English (US) ·
French (CA) ·
French (FR) ·